Drug news
FDA approves Solo Smart valve for Aortic Valve Disease-Sorin
Sorin Group has received FDA approval for the Solo Smart Aortic Pericardial Heart Valve, for use in patients with Aortic Valve Disease. It is the first valve with a removable stent to be approved in the US market.
Solo Smart is the evolution of the Freedom Solo valve, which has been implanted in international markets since 2004. This valve has been evaluated in numerous clinical studies representing over 4,000 patients with follow-up to 8 years.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins